[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$nktr Graphic](https://lunarcrush.com/gi/w:26/t:$nktr.png) $nktr

Nektar Therapeutics ($NKTR) sees a surge in social media activity due to potential settlement in the LLY lawsuit. Community anticipates settlement gains and future developments.

### About $nktr
Nektar Therapeutics ($NKTR) is a biotechnology company.  

### Insights [#](/topic/$nktr/insights)
- $nktr engagements is up XXXXXX% from the previous week.
- $nktr posts created is up XXXXXX% from the previous week.

### Engagements: XXXXXXX [#](/topic/$nktr/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/interactions.tsv)  
**Current Value**: XXXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX +119%  
**1 Month**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXXXX on 2025-06-24  
**1-Year Low**: XXX on 2025-10-12  

| Social Network | X       |
| -------------- | -       |
| Engagements    | XXXXXXX |
  

  
  
### Mentions: XXX [#](/topic/$nktr/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXX -XXXX%  
**1-Year High**: XXXXX on 2025-06-25  
**1-Year Low**: X on 2025-05-27  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XXX [#](/topic/$nktr/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning $nktr in the last XX hours which is up XX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Month**: XX -XXXX%  
**1-Year High**: XXXXX on 2025-06-25  
**1-Year Low**: X on 2025-05-24  

The most influential creators that mention $nktr in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@StockMKTNewz](/creator/twitter/StockMKTNewz)       | X    | XXXXXXX   | X     | XXXXXX      |
| [@pawcio2009](/creator/twitter/pawcio2009)           | X    | XXXXXX    | X     | XXXXXX      |
| [@SixSigmaCapital](/creator/twitter/SixSigmaCapital) | X    | XXXXXX    | X     | XXXXX       |
| [@seedy19tron](/creator/twitter/seedy19tron)         | X    | XXXXX     | X     | XXXXX       |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | X    | XXXXXX    | X     | XXXXX       |
| [@monaco_biotech](/creator/twitter/monaco_biotech)   | X    | XXXXX     | X     | XXXXX       |
| [@JD4for4](/creator/twitter/JD4for4)                 | X    | XXXXX     | X     | XXXXX       |
| [@ShortsellerST](/creator/twitter/ShortsellerST)     | X    | XXXXXX    | X     | XXXXX       |
| [@MitchMartan98](/creator/twitter/MitchMartan98)     | X    | XXXXX     | X     | XXXXX       |
| [@semodough](/creator/twitter/semodough)             | XX   | XXXXXX    | X     | XXXXX       |

[View More](/list/creators/$nktr/100)
  
  
### Sentiment: XX% [#](/topic/$nktr/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$nktr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$nktr/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +2%  
**1 Month**: XX% -XX%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-05-13  

**Most Supportive Themes**
- **Positive Sentiment:** (65%) Enthusiasm for the project's potential and future developments, especially regarding the LLY lawsuit and potential settlement gains.
  
**Most Critical Themes**
- **Market Volatility:** (35%)  Concerns about price fluctuations and market trends, with some users expressing caution.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXXX   | XX% | XXXXXXX | XX% | XXXXXX   | XX% |
|         |          |     |         |     |          |     |
| Total   | XXXXXX   | XX% | XXXXXXX | XX% | XXXXXX   | XX% |
  


**Top assets mentioned**
In the posts about $nktr in the last XX hours

[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Eli Lilly and Company (LLY)](/topic/$lly)
[Incyte Corporation (INCY)](/topic/$incy)
[uniQure N.V. (QURE)](/topic/$qure)
[Moderna Inc (MRNA)](/topic/$mrna)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Sanofi (SNY)](/topic/sanofi)
[Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge)
[Synthetify (SNY)](/topic/$sny)
[BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio)

**Top topics mentioned**
In the posts about $nktr in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [eli lilly](/topic/eli-lilly), [$lly](/topic/$lly), [$abvx](/topic/$abvx), [acquisition](/topic/acquisition), [$incy](/topic/$incy), [$qure](/topic/$qure), [$mrna](/topic/$mrna), [stocks technology](/topic/stocks-technology), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$crvs](/topic/$crvs), [stocks](/topic/stocks), [sanofi](/topic/sanofi), [$apge](/topic/$apge), [$sny](/topic/$sny), [$pali](/topic/$pali), [$bbio](/topic/$bbio), [$mrus](/topic/$mrus), [$cytk](/topic/$cytk), [investments](/topic/investments), [$vktx](/topic/$vktx), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$mstr](/topic/$mstr), [$xbi](/topic/$xbi), [stocks financial services](/topic/stocks-financial-services), [$be](/topic/$be), [coinbase](/topic/coinbase), [$mdgl](/topic/$mdgl), [has been](/topic/has-been), [$cdtx](/topic/$cdtx), [$insm](/topic/$insm), [$1b](/topic/$1b), [coins defi](/topic/coins-defi), [$crdo](/topic/$crdo), [$pltr](/topic/$pltr), [investment](/topic/investment), [$abcl](/topic/$abcl), [$mlys](/topic/$mlys), [$psnl](/topic/$psnl), [$idya](/topic/$idya), [$slno](/topic/$slno), [the only](/topic/the-only), [$kura](/topic/$kura), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [shutdown](/topic/shutdown), [$ptgx](/topic/$ptgx), [$kymr](/topic/$kymr), [$exel](/topic/$exel), [upside](/topic/upside), [advanced micro devices](/topic/advanced-micro-devices), [$rna](/topic/$rna), [meta platforms](/topic/meta-platforms), [$28bn](/topic/$28bn), [market cap](/topic/market-cap), [$beam](/topic/$beam), [coins bsc](/topic/coins-bsc), [momentum](/topic/momentum), [$drug](/topic/$drug), [jordan](/topic/jordan), [$2b](/topic/$2b), [all the](/topic/all-the), [$janx](/topic/$janx), [$1046m](/topic/$1046m), [gilead sciences](/topic/gilead-sciences), [$guts](/topic/$guts), [$mreo](/topic/$mreo), [$azn](/topic/$azn), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$ovid](/topic/$ovid), [$200m](/topic/$200m), [$meso](/topic/$meso), [approved](/topic/approved), [$zura](/topic/$zura), [$auph](/topic/$auph), [$nbis](/topic/$nbis), [corporate finance](/topic/corporate-finance), [$gsat](/topic/$gsat), [dd](/topic/dd), [monaco](/topic/monaco), [longterm](/topic/longterm), [united therapeutics corp](/topic/united-therapeutics-corp), [$mltx](/topic/$mltx), [$ntla](/topic/$ntla), [stocks industrials](/topic/stocks-industrials), [stocks utilities](/topic/stocks-utilities), [$mgnx](/topic/$mgnx), [$mnkd](/topic/$mnkd), [$myok](/topic/$myok), [coins dao](/topic/coins-dao), [volvo](/topic/volvo), [$vlvof](/topic/$vlvof), [money](/topic/money), [$srpt](/topic/$srpt), [$snys](/topic/$snys), [cuts](/topic/cuts), [$intc](/topic/$intc), [$ebc](/topic/$ebc), [coins gaming](/topic/coins-gaming), [$118k](/topic/$118k), [$evax](/topic/$evax)

### Top Social Posts [#](/topic/$nktr/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"2. $Lly is in a classic prisoner's dilemma. They know competitors know the best path for Lly is acquisition. $NKTR may have made them aware that other parties are interested in bidding. So the rope is getting tighter around the BO decision and importantly the offer $ amount"  
[X Link](https://x.com/Biolo_gic/status/1979516195670741102) [@Biolo_gic](/creator/x/Biolo_gic) 2025-10-18T11:53Z XXX followers, 1050 engagements


"Settlement offers rejected by $NKTR. Meanwhile Rezpeg clinical profile kept getting better and better with deepening responses and more validation in the crossover cohort. Nobody at $Lly wants to admit guilt by settling but I bet folks would love nailing an amazing asset"  
[X Link](https://x.com/Biolo_gic/status/1979516189953978858) [@Biolo_gic](/creator/x/Biolo_gic) 2025-10-18T11:53Z XXX followers, 1153 engagements


"$NKTR Betaville predicted INAR $2B BO two weeks before the deal was signed. Why I think NKTR BO could play out in a similar timeframe: X. We have a unique situation where $NKTR and $Lly are already sitting at the table for months. We know from depositions that Lly has made 👇"  
[X Link](https://x.com/Biolo_gic/status/1979516188683079815) [@Biolo_gic](/creator/x/Biolo_gic) 2025-10-18T11:53Z XXX followers, 8761 engagements


"dupi did almost $12B in AtD in 2024 TAM probably around $25B today rezpeg ph3+approval+ramp to peak=2032 TAM probably $30B+ by then XX% of mkt is $6B yes I think rezpeg can do $6B in rev (or more) **if all goes well**"  
[X Link](https://x.com/anthonystaj/status/1979476634018390515) [@anthonystaj](/creator/x/anthonystaj) 2025-10-18T09:16Z 2658 followers, 18.3K engagements